rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ALXO
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      ALX Oncology at UBS conference: two pipeline bets near key tests
      Nov 17Investing.comALXOUBS
      ALX Oncology to Present at Upcoming Investor Conferences

      SOUTH SAN FRANCISCO, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in fireside chats at three upcoming investor conferences. The details of the meetings are as follows: UBS London Healthcare Conference Format: Fireside Chat and One-on-one MeetingsDate

      Nov 10Yahoo FinanceALXO
      Wells Fargo Remains a Buy on ALX Oncology Holdings (ALXO)

      Tipranks Press Release.

      Oct 19The Globe and MailALXO
      Analysts Are Bullish on These Healthcare Stocks: ALX Oncology Holdings (ALXO), United Therapeutics (UTHR)

      Tipranks Press Release.

      Oct 19The Globe and MailALXO
      ALX Oncology reports trial data for gastric cancer drug
      Sep 28Investing.comALXO
      Analysts Are Bullish on Top Healthcare Stocks: ALX Oncology Holdings (ALXO), Tonix Pharma (TNXP)

      Detailed price information for Alx Oncology Holdings Inc (ALXO-Q) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailALXOTNXP
      ALX Oncology at H.C. Wainwright conference: two drug bets near key tests
      Sep 14Investing.comALXO
      ALX Oncology at Cantor healthcare conference: biomarker push takes center stage
      Sep 10Investing.comALXO
      ALX Oncology at Wells Fargo conference: two drugs near key tests
      Sep 9Investing.comALXOWFC
      ALX Oncology to Present at Upcoming Investor Conferences in September

      SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in fireside chats at three upcoming investor conferences. The details of the meetings are as follows: Wells Fargo 21st Annual Healthcare Conference Format: Fireside Chat and One-on-on

      Sep 2Yahoo FinanceALXO

      This is the newest page. Registered accounts read further back.